Development Pharmaceutics Practice for sale

A pharmaceutics product development facility. Other 3 new medicines are currently in development.

One of these drugs is a newer antibiotic for pigs and cattle. This medicine is expected to be approved by FDA for sale in 2021. The other two drugs are for humans. One of the drugs is a pain reliever (for nausea, cancer pain), and the other is intended for diabetics. It is essential that such drugs meet the criteria for Orphan Drugs and Exclusive for Children. Presumably, the FDA will approve these drugs in 2026.

Revenue from the three drugs is projected to exceed $ 120 million by 2026. All drugs that are in developing have huge markets, therefore, they will generate significant income.

The funds obtained will be used for clinical trials and during the licensing process of medicines that are in development.